NM_000127.3:c.1056+2T>A
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000127.3(EXT1):c.1056+2T>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000127.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- exostoses, multiple, type 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen
- chondrosarcomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- hereditary multiple osteochondromasInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EXT1 | ENST00000378204.7 | c.1056+2T>A | splice_donor_variant, intron_variant | Intron 2 of 10 | 1 | NM_000127.3 | ENSP00000367446.3 | |||
| EXT1 | ENST00000436216.2 | n.423+2T>A | splice_donor_variant, intron_variant | Intron 2 of 5 | 3 | ENSP00000400372.1 | ||||
| EXT1 | ENST00000437196.1 | n.74-1555T>A | intron_variant | Intron 1 of 9 | 5 | ENSP00000407299.1 | ||||
| EXT1 | ENST00000684189.1 | n.523+2T>A | splice_donor_variant, intron_variant | Intron 2 of 10 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Multiple congenital exostosis Pathogenic:1
This sequence change affects a donor splice site in intron 2 of the EXT1 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with an EXT1-related disease. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in EXT1 are known to be pathogenic (PMID: 19810120, 10679937, 11391482). For these reasons, this variant has been classified as Pathogenic. -
not provided Other:1
Variant classified as not provided and reported on 03-19-2019 by Eurolab. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at